Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie Rossjohn

Showing results (321-330 of 534) with videos related to

Pageof 54
Sort By:
The Journal of Experimental Medicine|November 9, 2005
The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformationFleur E Tynan, Diah Elhassen, Anthony W Purcell, et al.
The Journal of Biological Chemistry|March 12, 2015
The structure of the atypical killer cell immunoglobulin-like receptor, KIR2DL4Shoeib Moradi, Richard Berry, Phillip Pymm, et al.
Science Immunology|October 14, 2018
A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligandsPouya Faridi, Chen Li, Sri H Ramarathinam, et al.
Nature Immunology|February 14, 2006
Structural basis for a major histocompatibility complex class Ib-restricted T cell responseHilary L Hoare, Lucy C Sullivan, Gabriella Pietra, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2011
NKT TCR recognition of CD1d-α-C-galactosylceramideOnisha Patel, Garth Cameron, Daniel G Pellicci, et al.
Nature Structural & Molecular Biology|February 21, 2017
MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escapePhillip Pymm, Patricia T Illing, Sri H Ramarathinam, et al.
Nature|June 23, 2012
Immune self-reactivity triggered by drug-modified HLA-peptide repertoirePatricia T Illing, Julian P Vivian, Nadine L Dudek, et al.
Plos Biology|June 21, 2017
MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppressionChristopher R Shaler, Joshua Choi, Patrick T Rudak, et al.
Cell Reports|March 5, 2020
Virus-Mediated Suppression of the Antigen Presentation Molecule MR1Brian P McSharry, Carolyn Samer, Hamish E G McWilliam, et al.
Nature Immunology|January 30, 2007
A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I moleculeFleur E Tynan, Hugh H Reid, Lars Kjer-Nielsen, et al.
Pageof 54

Showing results (321-330 of 534) with videos related to

Sort By:
Pageof 54
The Journal of Experimental Medicine|November 9, 2005
The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformationFleur E Tynan, Diah Elhassen, Anthony W Purcell, et al.
The Journal of Biological Chemistry|March 12, 2015
The structure of the atypical killer cell immunoglobulin-like receptor, KIR2DL4Shoeib Moradi, Richard Berry, Phillip Pymm, et al.
Science Immunology|October 14, 2018
A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligandsPouya Faridi, Chen Li, Sri H Ramarathinam, et al.
Nature Immunology|February 14, 2006
Structural basis for a major histocompatibility complex class Ib-restricted T cell responseHilary L Hoare, Lucy C Sullivan, Gabriella Pietra, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2011
NKT TCR recognition of CD1d-α-C-galactosylceramideOnisha Patel, Garth Cameron, Daniel G Pellicci, et al.
Nature Structural & Molecular Biology|February 21, 2017
MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escapePhillip Pymm, Patricia T Illing, Sri H Ramarathinam, et al.
Nature|June 23, 2012
Immune self-reactivity triggered by drug-modified HLA-peptide repertoirePatricia T Illing, Julian P Vivian, Nadine L Dudek, et al.
Plos Biology|June 21, 2017
MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppressionChristopher R Shaler, Joshua Choi, Patrick T Rudak, et al.
Cell Reports|March 5, 2020
Virus-Mediated Suppression of the Antigen Presentation Molecule MR1Brian P McSharry, Carolyn Samer, Hamish E G McWilliam, et al.
Nature Immunology|January 30, 2007
A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I moleculeFleur E Tynan, Hugh H Reid, Lars Kjer-Nielsen, et al.
Pageof 54